August 3, 2021 Comments Off on New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Posted in: Uncategorized
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent expiration for Glaxosmithkline drug …
August 3, 2021 Comments Off on New patent expiration for Glaxo Grp drug BREO ELLIPTA Posted in: Uncategorized
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
